Ticker: CLPT

ClearPoint Neuro, Inc. (NASDAQ: CLPT) - Quick internal read What's happening inside: management is scaling commercialization (SmartFrame OR, Prism laser, OS 3.0) and biologics/drug‑delivery services while investing heavily in R&D and commercial headcount. In May 2025 the company completed a smal...

ClearPoint Neuro, Inc. (NASDAQ: CLPT) has reported its financial performance for the first quarter of 2025, reflecting a mixed bag of results on its income statement. Below are the key highlights of the company's financial position and performance: Total Revenue: Increased by 11% to $8.5 million...